Related Experiment Video
Updated: Jun 27, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
[Vaccination in patients with systemic diseases]
Thomas Hanslik1, Paula Niedziolka, Solen Kernéis
1Service de Médecine Interne, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Université de Versailles Saint-Quentin-en-Yvelines, Boulogne-Billancourt Cedex, France. thomas.hanslik@apr.aphp.fr
Abstract:
The incidence of vaccine-preventable infections in the context of systemic diseases is not quantified. Available data on immunogenicity and safety of vaccination in subjects treated for systemic disease are few and come from studies of low level of evidence. Keeping in mind these limitations, these studies show that the vaccines are well tolerated and often immunogenic, when administered in accordance with their contra-indications and the immunization schedule. These findings are an encouragement to properly immunize patients with systemic diseases. Measures should be taken to improve immunization coverage for these patients and their entourage.
More Related Videos
Related Concept Videos
Vaccinations
Vaccines
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Smallpox
Microorganisms in Medicine and Therapeutics

